Vitamin D Deficiency and Cancer Survival Disparities

Released: 6/8/2012 1:50 PM EDT
Source Newsroom: Sunlight, Nutrition and Health Research Center
Contact Information

Available for logged-in reporters only

Citations Dermato-Endocrinology (4(2), 2012)

Newswise — A paper just published in Dermato-Endocrinology suggests that vitamin D deficiency may account for unexplained disparities in cancer survival rates between African and White Americans. There is a large body of scientific literature supporting the role of solar ultraviolet-B (UVB) light and vitamin D in reducing incidence and mortality rates of many types of cancer. In addition, papers have reported that those with higher serum 25-hydroxyvitamin D concentrations when diagnosed with seven types of cancer have higher cancer-specific and all-cause survival rates.

Much of the journal literature regarding disparities in cancer survival rates between African- and white-Americans examines the roles of socioeconomic status, stage at diagnosis, and treatment. While these factors do explain a significant portion of the disparities, most of the studies report that these factors do not explain all of the disparities.

The journal literature indicates that there are disparities for 13 types of cancer after consideration of socioeconomic status, stage at diagnosis and treatment: bladder, breast, colon, endometrial, lung, ovarian, pancreatic, prostate, rectal, testicular, and vaginal cancer; Hodgkin’s lymphoma; and melanoma. Solar UVB doses and/or vitamin D have been reported inversely correlated with incidence and/or mortality rates for all of these cancers.

The unexplained portion is generally between zero and 30%, with an average near 15%. A disparity of 25% is expected from a consideration of serum vitamin D concentrations for African-Americans (16 ng/ml or 40 nmol/l) and white-Americans (25 ng/ml or 63 nmol/l) based on relations between serum vitamin D concentrations and incidence rates for breast and colorectal cancer. However, the effect for other cancers may be lower than for breast and colorectal cancer.

African-Americans have vitamin D concentrations lower than white-Americans since their darker skin pigmentation reduces the penetration of UVB, thus, reduces the production of vitamin D. Dark skin is an advantage in Africa, where solar UVB doses are quite high, but a disadvantage in the United States, where it isn’t.

According to William B. Grant, Ph.D., a coauthor of the paper and director of Sunlight, Nutrition and Health Research Center, “Raising vitamin D concentrations to 40 ng/ml by taking 1000-4000 IU/d vitamin D3 supplements is the easiest thing African-Americans can do to reduce the heavy burden of cancer they experience. In addition to reducing the risk of cancer, vitamin D would also reduce the risk of cardiovascular disease, diabetes mellitus, respiratory infections and many other chronic and infectious diseases.”

According to Alan N. Peiris, M.D,PhD. FRCP(Lon), a co-author and Chief of Endocrinology at Mountain Home VAMC and East Tennessee State University, monitoring of vitamin D status is often inadequate. Given the wide range of dose responses to vitamin D replacement, it is prudent to monitor levels of 25(OH)D following initiation of dosing. This enables maintaining desired levels over the long term which may facilitate accrual of maximal benefit.

According to Emily Allison-Francis, author of Correcting the Vitamin D Deficiency: Strategies to Fight Diseases and Prolong Life for Black People, says:
“Vitamin D deficiency is at epidemic proportions in the United States and it is far worse among blacks. This paper provides much needed insight into the important role which vitamin D deficiency plays in helping to explain the significantly higher cancer incidence and mortality rates among African Americans.”

According to David A. McCarthy, M.D. Illinois:
“Those who have the lowest vitamin D levels have the most potential to gain from repletion.

Research into the basic science of vitamin D has demonstrated profound effects on cell proliferation, cell differentiation, angiogenic tumor factors and cell cohesion. Each of these factors plays a major role in the evolution and progression of cancers.

Testing for 25 (OH) vitamin D is simple, widely available and cost effective. Those who have the lowest 25 (OH) D levels have the most potential to gain from repletion. Based on the current state of knowledge, the risk:benefit of repletion of vitamin D stores is favorable. More than 50% of Americans over 50 years of age will have one or more malignancies diagnosed. Hypovitaminosis D disproportionately affects African-Americans. It’s time to level the playing field.”

The paper is available at
http://www.landesbioscience.com/journals/dermatoendocrinology/article/19667/

Information about the authors:
William B. Grant, Ph.D., is the director of Sunlight, Nutrition and Health Research Center, a public charitable non-profit organization in San Francisco devoted to research and education on the primary risk-modifying factors for chronic and infectious diseases. He has over 150 publications on vitamin D, of which over 60 also discussed ultraviolet radiation.

Alan N. Peiris, MBBS, MD (London), MRCP (UK), FACP, FACE, MRCS is Professor, Chief, Division of Endocrinology, Department of Internal Medicine Eastern Tennessee State University and Chief of Endocrinology at the Mountain Home Veterans Administration Medical Clinic.

They collaborated in 2010 on this related paper:
Grant WB, Peiris AN. Possible role of serum 25-hydroxyvitamin D in Black–White health disparities in the United States. J Am Med Directors Assoc. 2010 Nov;11(9):617-28.


Comment/Share